Lazard (LAZ) Stock
Global financial advisory and asset management specialist. Here's the price, business snapshot, and what's worth knowing about Lazard in October 2026.
Lazard Ltd (LAZ) is a specialist global financial advisory and asset management firm offering M&A and restructuring advice, capital structure guidance, and investment management for institutions and private clients. With a market capitalisation around $4.8 billion, Lazard’s revenues are closely tied to deal flow, market valuations and assets under management, which makes results cyclical and sensitive to economic conditions. Investors should note its fee-based and performance-related income mix, a broad international footprint across the Americas, Europe and Asia, and competition from larger banks and boutiques. Key risks include variability in transaction volumes, retention of senior advisory talent, regulatory oversight and market-driven asset performance. Assessing Lazard typically involves watching announced mandates, assets under management trends, margin progress and management commentary. This summary is for educational purposes only and not personalised advice; values can rise or fall and past performance is not a reliable guide to the future. Consider your risk tolerance or consult a qualified adviser before investing.
Lazard (LAZ) Stock Forecast
Analyst price target, next 12 months
$47.14
+26.7% vs today's $37.21
Price range over the last 12 months
Close to its 12-month low
Analysts covering Lazard have a consensus 12-month target of $47.14, above the current price of $37.21.
Analyst targets are opinions, not guarantees. Capital at risk. Data as of 25 Oct 2026.
Source: Analyst sentiment is provided by Refinitiv Ltd, a global leader in financial market data with over 40k business clients. Refinitiv Ltd is an independent third party to Nemo. This is not advice.
Sixth Month Growth Performance
Stock Performance Snapshot
Analyst Rating
Analysts suggest holding Lazard's stock with a target price of $47.14, indicating potential growth.
Financial Health
Lazard is showing strong financial performance with good cash flow and solid book value per share.
Dividend
Lazard's average dividend yield of 3.24% makes it a decent choice for dividend-seeking investors. If you invested $1000 you would be paid $32.40 a year in dividends (based on the last 12 months).
Why You’ll Want to Watch This Stock
Deal-driven revenue
Advisory fees rise with M&A and restructuring activity, which can boost results — though revenues can also swing sharply with market cycles.
Global footprint matters
A presence across regions helps diversify mandates and client types, but geopolitical and regulatory changes can affect business in specific markets.
People-driven value
Senior bankers and investment teams generate mandates and client relationships, so talent retention is a core operational risk and opportunity.
Why invest with Nemo?
Zero Commission
Trade stocks, ETFs, and more with zero commission. Keep more of your returns.
Trusted & Regulated
Part of Exinity Group 2015, serving over a million customers globally.
